Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2124774rdf:typepubmed:Citationlld:pubmed
pubmed-article:2124774lifeskim:mentionsumls-concept:C0012544lld:lifeskim
pubmed-article:2124774lifeskim:mentionsumls-concept:C0016037lld:lifeskim
pubmed-article:2124774lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:2124774pubmed:issue10lld:pubmed
pubmed-article:2124774pubmed:dateCreated1991-2-5lld:pubmed
pubmed-article:2124774pubmed:abstractTextFibrodysplasia ossificans progressiva (FOP) is a severe, rare, autosomal dominant, ectopic ossifying condition, with primary involvement of the skeletal muscles associated with skeletal abnormalities. This report concerns an 11-year-old boy suffering from FOP, who presented significant modification of the musculoskeletal structure of the thorax and problems with articular movements. The patient showed progress after treatment with ethane-1-hydroxy-1,1-diphosphonate (EHDP). In fact, using a scintiscanner we were able to observe a significant improvement in symptoms and a recovery of some of the active sites of ossification.lld:pubmed
pubmed-article:2124774pubmed:languageenglld:pubmed
pubmed-article:2124774pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124774pubmed:citationSubsetIMlld:pubmed
pubmed-article:2124774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124774pubmed:statusMEDLINElld:pubmed
pubmed-article:2124774pubmed:monthOctlld:pubmed
pubmed-article:2124774pubmed:issn0001-656Xlld:pubmed
pubmed-article:2124774pubmed:authorpubmed-author:BruniLLlld:pubmed
pubmed-article:2124774pubmed:authorpubmed-author:ImperatoCClld:pubmed
pubmed-article:2124774pubmed:authorpubmed-author:TozziM CMClld:pubmed
pubmed-article:2124774pubmed:authorpubmed-author:ScopinaroFFlld:pubmed
pubmed-article:2124774pubmed:authorpubmed-author:GiammariaPPlld:pubmed
pubmed-article:2124774pubmed:authorpubmed-author:CamparcolaDDlld:pubmed
pubmed-article:2124774pubmed:issnTypePrintlld:pubmed
pubmed-article:2124774pubmed:volume79lld:pubmed
pubmed-article:2124774pubmed:ownerNLMlld:pubmed
pubmed-article:2124774pubmed:authorsCompleteYlld:pubmed
pubmed-article:2124774pubmed:pagination994-8lld:pubmed
pubmed-article:2124774pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:2124774pubmed:meshHeadingpubmed-meshheading:2124774-...lld:pubmed
pubmed-article:2124774pubmed:meshHeadingpubmed-meshheading:2124774-...lld:pubmed
pubmed-article:2124774pubmed:meshHeadingpubmed-meshheading:2124774-...lld:pubmed
pubmed-article:2124774pubmed:meshHeadingpubmed-meshheading:2124774-...lld:pubmed
pubmed-article:2124774pubmed:meshHeadingpubmed-meshheading:2124774-...lld:pubmed
pubmed-article:2124774pubmed:meshHeadingpubmed-meshheading:2124774-...lld:pubmed
pubmed-article:2124774pubmed:year1990lld:pubmed
pubmed-article:2124774pubmed:articleTitleFibrodysplasia ossificans progressiva. An 11-year-old boy treated with a diphosphonate.lld:pubmed
pubmed-article:2124774pubmed:affiliationDepartment of Paediatrics, University of Rome, La Sapienza, Italy.lld:pubmed
pubmed-article:2124774pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2124774pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2124774lld:pubmed